JP2025517138A5 - - Google Patents
Info
- Publication number
- JP2025517138A5 JP2025517138A5 JP2024565193A JP2024565193A JP2025517138A5 JP 2025517138 A5 JP2025517138 A5 JP 2025517138A5 JP 2024565193 A JP2024565193 A JP 2024565193A JP 2024565193 A JP2024565193 A JP 2024565193A JP 2025517138 A5 JP2025517138 A5 JP 2025517138A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- particle according
- virus
- virus particle
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263339332P | 2022-05-06 | 2022-05-06 | |
| US63/339,332 | 2022-05-06 | ||
| US202263348180P | 2022-06-02 | 2022-06-02 | |
| US63/348,180 | 2022-06-02 | ||
| US202263351064P | 2022-06-10 | 2022-06-10 | |
| US63/351,064 | 2022-06-10 | ||
| US202363487734P | 2023-03-01 | 2023-03-01 | |
| US63/487,734 | 2023-03-01 | ||
| PCT/US2023/066636 WO2023215848A1 (en) | 2022-05-06 | 2023-05-05 | Viral particle with surface stimulating molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025517138A JP2025517138A (ja) | 2025-06-03 |
| JP2025517138A5 true JP2025517138A5 (enExample) | 2026-05-15 |
Family
ID=88647221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024565193A Pending JP2025517138A (ja) | 2022-05-06 | 2023-05-05 | 表面刺激分子を有するウイルス粒子 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250051801A1 (enExample) |
| EP (1) | EP4519422A1 (enExample) |
| JP (1) | JP2025517138A (enExample) |
| KR (1) | KR20250008769A (enExample) |
| CN (1) | CN119497751A (enExample) |
| AU (1) | AU2023265993A1 (enExample) |
| CA (1) | CA3251286A1 (enExample) |
| IL (1) | IL316109A (enExample) |
| MX (1) | MX2024013608A (enExample) |
| WO (1) | WO2023215848A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202009975TA (en) | 2018-04-12 | 2020-11-27 | Umoja Biopharma Inc | Viral vectors and packaging cell lines |
| EP4045663A2 (en) * | 2019-10-16 | 2022-08-24 | Umoja Biopharma, Inc. | Retroviral vector for univeral receptor therapy |
| CN120457212A (zh) * | 2022-11-04 | 2025-08-08 | 优莫佳生物制药股份有限公司 | 展示融合分子的慢病毒颗粒及其用途 |
| US20260176651A1 (en) * | 2022-11-04 | 2026-06-25 | Umoja Biopharma, Inc. | Particles displaying adhesion-molecule fusions |
| WO2025203091A2 (en) * | 2024-03-26 | 2025-10-02 | Micro Crispr Pvt. Ltd. | Surface modification of lentiviral particle and producer cell thereof |
| WO2025235604A1 (en) * | 2024-05-08 | 2025-11-13 | Umoja Biopharma, Inc. | Fusion protein for use as immune cell engager |
| WO2025235605A1 (en) * | 2024-05-08 | 2025-11-13 | Umoja Biopharma, Inc. | Multispecific immune cell engager and uses thereof |
| WO2026051968A1 (zh) * | 2024-09-04 | 2026-03-12 | 深圳易慕峰生物科技股份有限公司 | 一种新型病毒颗粒及其应用 |
| WO2026136737A1 (en) * | 2024-12-19 | 2026-06-25 | Umoja Biopharma, Inc. | Cd58-pseudotyped viral particles and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016303497A1 (en) * | 2015-07-31 | 2018-03-01 | Tarveda Therapeutics, Inc. | Compositions and methods for immuno-oncology therapies |
| SG11202009975TA (en) * | 2018-04-12 | 2020-11-27 | Umoja Biopharma Inc | Viral vectors and packaging cell lines |
-
2023
- 2023-05-05 KR KR1020247040511A patent/KR20250008769A/ko active Pending
- 2023-05-05 EP EP23800248.9A patent/EP4519422A1/en active Pending
- 2023-05-05 CN CN202380038869.2A patent/CN119497751A/zh active Pending
- 2023-05-05 WO PCT/US2023/066636 patent/WO2023215848A1/en not_active Ceased
- 2023-05-05 IL IL316109A patent/IL316109A/en unknown
- 2023-05-05 CA CA3251286A patent/CA3251286A1/en active Pending
- 2023-05-05 JP JP2024565193A patent/JP2025517138A/ja active Pending
- 2023-05-05 AU AU2023265993A patent/AU2023265993A1/en active Pending
-
2024
- 2024-10-30 US US18/931,597 patent/US20250051801A1/en active Pending
- 2024-11-04 MX MX2024013608A patent/MX2024013608A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022204601B2 (en) | Methods for enhancing efficacy of therapeutic immune cells | |
| JP2024074937A (ja) | 細胞免疫療法のための方法および組成物 | |
| AU2015254595B2 (en) | CS1 specific multi-chain chimeric antigen receptor | |
| US20180002427A1 (en) | Cll1-specific multi-chain chimeric antigen receptor | |
| US11866494B2 (en) | CAR T therapy through uses of co-stimulation | |
| US20180134795A1 (en) | Cd123 specific multi-chain chimeric antigen receptor | |
| WO2019191125A1 (en) | Methods of making and using guidance and navigation control proteins | |
| CA2956482A1 (en) | Ror1 specific multi-chain chimeric antigen receptor | |
| CN112430580A (zh) | 用于免疫疗法的组合物和方法 | |
| JP2023517063A5 (enExample) | ||
| CN108138148A (zh) | T细胞的激活和扩增 | |
| JP7812549B2 (ja) | 人工免疫監視キメラ抗原受容体（ａｉ－ｃａｒ）及びそれを発現する細胞 | |
| CN110257338A (zh) | 嵌合细胞因子受体 | |
| US20240131068A1 (en) | Car-t constructs comprising a novel cd19 binder combined with il18 and methods of using the same | |
| WO2021027785A1 (zh) | 共表达趋化因子受体的免疫效应细胞 | |
| US20220056411A1 (en) | Methods for isolating cd8+ selected t cells | |
| JP2024531910A5 (enExample) | ||
| JP2022001021A (ja) | Ｃｄ２６特異的キメラ抗原受容体 | |
| CN117683136A (zh) | 嵌合抗原受体、慢病毒、修饰nk细胞及其应用 | |
| AU2015295348B2 (en) | ROR1 specific multi-chain chimeric antigen receptor | |
| AU2024207657A1 (en) | Blockade of cd8 expression and chimeric antigen receptors for immunotherapy of t-cell and nk-cell malignancies | |
| AU2015295348A1 (en) | ROR1 specific multi-chain chimeric antigen receptor |